TB notes by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
1 
 
DEPARTMENT OF HEALTH & HUMAN SERVICES                                                             Public Health Service 
___________________________________________________________________________________________ 
Centers for Disease Control 
and Prevention (CDC) 
                 Atlanta GA 30333 
TB Notes 




This summer has brought a number of staffing changes to the Division of Tuberculosis 
Elimination (DTBE). As you know, our former Director, Dr. Kenneth Castro, left DTBE in 
August 2013 when he was asked to serve as Acting Director of the Division of HIV/AIDS 
Prevention (DHAP) and officially vacated the position last December. Since that time, I have 
been serving as DTBE Acting Director. I am honored to have been selected as the new 
Director of DTBE and officially began serving in this position as of August 11. 
 
I am pleased and proud to be taking the helm of this Division. My reasons for being proud are 
as varied and numerous as the 175+ staff members working in DTBE. Thank you for your 
patience as we worked through this process. And thank you for all your congratulations and 
good wishes. 
 
We have had other leadership changes in the division as well. Bonnie Plikaytis, Acting Chief of 
the Laboratory Branch (LB), retired in June, and Angela Starks, PhD, was selected as Chief of 
LB. Jose Becerra, MD, Chief, Data Management and Statistics Branch (DMSB), also retired 
this summer; Chad Heilig, PhD, is serving as Acting Chief. Eugene McCray, MD, Chief of the 
International Research and Programs Branch (IRPB), was selected to serve as the Director of 
DHAP beginning August 11, 2014; Eric Pevzner, PhD, is serving as Acting Chief. Beverly 
DeVoe-Payton, MS, Deputy Chief of the Clinical Research Branch, retired in August.  In 
addition, William R. Mac Kenzie, MD, Supervisory Medical Officer and Team Lead within the 
Clinical Research Branch (CRB), has been selected as the Center for Surveillance, 
Epidemiology and Laboratory Services (CSELS) Deputy Director for Science; he will join 
CSELS in September. You may read more about these and other staff changes in this issue as 
well as in the previous issue of TB Notes. 
 
The 2014 National TB Conference was held in Atlanta June 11–13, with the theme of “Sharing 
the Vision of TB Elimination.” Following is a summary, for the benefit of those who were unable 
to attend. Pre-meetings were held on June 10, with the new Epidemiology Section of the 
National TB Controllers Association (NTCA) meeting for the first time. On June 11, during the 
first general session entitled “Defining the Vision of TB Elimination,” Dr. Jenny Flood discussed 
challenges for TB control and elimination, and Dr. Jonathan Mermin discussed, “What are the 
big unanswered questions?” Dr. Dick Menzies provided the keynote speech on “What’s Really 
Limiting Treatment of TB Infection?” He suggested that the problem with latent TB infection 
(LTBI) is not getting people to complete LTBI, but in getting many more of the correct people, 
such as close contacts, to actually start it. 
 
The second general session was devoted to using epidemiology to inform public health 
intervention in key populations. Dr. Tom Navin, moderator for the session, concisely summed 
up the session with the statement, “Just because cases overall are declining, does not mean 
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that cases in subpopulations are declining ... keep an eye on sentinel populations to get an 
early warning of potential problems.” 
 
The third general session was titled, “From Here to Elimination: Diagnosing and Treating TB 
Infection.” The session included presentations on the TB skin test and the TB blood tests, the 
different regimens available such as 4 months rifampin (RIF) and 12-dose isoniazid/rifapentine 
(INH/RPT), and using risk assessments to target the populations who would benefit the most 
from LTBI treatment (close contacts and foreign-born persons). 
 
On Thursday morning, the Regional Training and Medical Consultation Centers (RTMCCs) 
held break-out sessions for NTC attendees from their respective regions. This was followed by 
the fourth general session, “Applied Innovations for TB Control and Elimination.” There were 
two talks on an initiative called ECHO (Extension for Community Healthcare Outcomes); using 
video-conferencing technology, the ECHO program trains primary care providers to treat 
remotely located patients with complex diseases. We heard a talk on using social media to 
enhance routine TB control, and we also heard several presentations on different ways to do 
video observed therapy. At a break in mid-afternoon, the 2014 NTCA awards were presented; 
please see the related article in this issue. Later that afternoon, we had a choice of five 
different break-out sessions to attend on topics that included innovative uses of genotyping, 
stories of TB survivors, treating multidrug-resistant (MDR) TB to cure, TB and diabetes, and an 
update on the Division of Global Migration and Quarantine’s (DGMQ) technical instructions.  
 
On Friday morning, at the start of general session five, NTCA poster competition winners were 
announced; we include that report here. The general session, “Sharing the Vision with Our 
Partners,” provided an opportunity to hear from partners such as the Treatment Action Group 
(TAG) and TB Voices, the Migrant Clinicians’ Network, the National Health Care for the 
Homeless Council, Stop TB USA, and public health laboratories. We heard about the concept 
of an LTBI reporting system for the states, as well as the voices of former TB patients. Dr. 
John Bernardo provided closing remarks, and at noon the meeting was officially adjourned. 
 
I believe we have now entered a more stable time, with the resolution of various leadership 
vacancies and with another successful National TB Conference behind us. I look forward to all 
of us being able to work with renewed energy and focus on the tasks at hand and continue the 
successful inroads we are making against tuberculosis. I sincerely hope all of you have a safe, 





       Philip LoBue, MD, FACP, FCCP 
       Director 
       Division of Tuberculosis Elimination 
       National Center for HIV/AIDS, Viral Hepatitis, 
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HIGHLIGHTS FROM STATE AND 
LOCAL PROGRAMS 
 
2014 NTCA Special Awards 
 
In 2010, the NTCA initiated annual awards to 
recognize individual TB program staff and partners 
whose contributions to our shared goal of TB 
elimination were exceptional. These awards have 
continued, and the following were recognized at the 








has made an 
outstanding effort 
or achievement in 
advocating for 
increased support 
and recognition of 
TB control and 
prevention 
efforts. The 2014 winners of the Advocacy Award are 
Natalie Nelson Skipper and Jigna Rao, both TB 
survivors. They have been vigilant and passionate 
about (1) raising awareness of the struggles faced by 
patients experiencing this infectious disease; (2) 
describing the critical role of public health TB 
programs and staff in their own TB journey and the 
journeys of others; (3) the precarious state of these 
programs because of funding cuts; and (4) the urgent 
need for increased awareness of this disease and 
funding to support programs, operational and 
transitional research, and new drugs and drug 
combinations to significantly reduce the treatment 
time and toxic side effects.  
No story is more powerful than that of someone 
affected by TB. Natalie’s and Jigna’s contributions 
have made an impact on local, state, national and 
global levels. Both are working with NTCA to bring a 
comfort level and sense of urgency among our public 
health professionals to reach out and ask patients to 
“tell their own story” as healing, education, and 
validation of the experiences promote trust and gives 
meaning to the experience! We are deeply grateful 
for the lives of these two women and their 
contributions to raising awareness about the impact 
of this disease. 
 
TB Controller of 
the Year 
This is the National 
Tuberculosis 
Controller’s highest 
award. It recognizes 
an outstanding 
contribution and 
impact on TB 
prevention and 
control at the local, 
state, regional, or 
national level.  
Dr. Masa Narita, 
Director of TB for 
Seattle’s TB 
program, is the 
2014 TB Controller 
of the Year. When starting as a TB controller, Masa 
walked into a large epidemic among the homeless in 
Seattle. From this inauguration, not only did he 
become an innovator for TB control and homeless 
shelters, he went on to create a legacy of TB control 
contributions. As a long-standing ACET member, he 
has fought for adopting a vision that would advance 
TB control and elimination, desperately needed now 




Centers for Disease Control and Prevention 
Atlanta, Georgia  30333 
Division of Tuberculosis Elimination ♦ 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 
From left: Natalie Skipper and 
Jigna Rao receiving NTCA’s 
Charles DeGraw Advocacy 
Award from Drs. Jon Warkentin 
and Jennifer Flood. 
Dr. Masa Narita (left) received the 
NTCA’s TB Controller award. 
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Masa is a respected leader in the TB community and, 
as an outstanding TB physician himself, understands 
both the programmatic and clinical side of the work 
we do. Many are awed by his intelligence, diligence, 
focus, compassion, and dedication. He is a 
meticulous researcher who has the gift to be able to 
take his findings and communicate them in a fashion 
that can be translated into our everyday practice. 
Masa brings pragmatism and vision to TB research 
and has published extensively. He is well-loved by 
patients and admired by colleagues and generously 
shares his knowledge in his teaching roles and as a 
warmline consultant with the Curry International TB 
Center. Masa’s numerous contributions to TB control 
are making a significant impact in his local area and 
state, as well as at the national level. He is to be 
commended for these contributions and is well 
deserving of this prestigious award.  
  
William Stead TB Clinician Award 
This award recognizes outstanding commitment and 
performance by a clinician providing tuberculosis 
care, leadership, or mentoring. Dr. Randall Reves is 
this year’s TB Clinician of the Year. Randall has 
worked in public health, specifically as a clinician 
treating those with TB, since the late 1980s. 
Throughout his career, he has championed those 
who do not have a voice, giving them hope and 
dignity while restoring their health. In addition to his 
career in academic medicine, Randall served as the 
Director of the Denver Metro TB Control Program 
from 1990 until his retirement in February 2013. 
 
He has mentored many young physicians who have 
made significant contributions to the field of TB 
research and clinical care. In this regard, he has 
been a champion for changing the way public health 
service and leadership is viewed by the bright young 
healthcare leaders of tomorrow; his mentorees have 
embraced Randall’s dedication and passion for 
serving and protecting the public’s health and our 
community is richer for their contributions. Dr. Bob 
Belknap, Immediate Past President of the National 
Society of TB Clinicians, has this to say about Dr. 
Reves: “Personally, he has been an outstanding 
mentor for me, beginning during my infectious 
diseases fellowship and continuing today. He is a role 
model for all who work with him on how to provide 
excellent patient care. By combining intelligence, 
patience, and a humble demeanor, he is able to 
make complex medical decisions while also 
considering the larger context for the patient, public 
health, and Denver Health.” 
 
Randall’s outstanding contributions leave a lasting 
legacy in TB public health, at a state and a national 
level, and his efforts have reduced suffering and 
deaths due to TB. Hardly retired, Randall continues 
to push for progress towards the eventual elimination 
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Randall Reves (center) received the NTCA’s 
William Stead TB clinician award. 
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of TB in the United States with his eloquent and 
prolific pen, and his dedication to protecting the 
public’s health and advancing the need for safer and 
shorter treatment regimens. 
Carol Pozsik TB Nurse Award 
This award honors exemplary care, service, 
dedication, or leadership in the field of TB nursing. 
Ann Jackson, this year’s award recipient, is a Nurse 
Consultant with the Mississippi State Department of 
Health and has work in TB for 15 years. Originally 
hired as a contract employee, her abilities and 
compatibility with TB public health work were 
recognized and after just 2 years, Ann was hired as a 
TB Nurse Consultant for the state.  
 
Two of the numerous letters of support submitted 
with Ann’s nomination described her in this way: 
“dedication, competence, professionalism, expert, 
effective, savvy” and “a role model for all TB nurses.” 
In addition to her TB nursing expertise, Ann is a 
competent, effective and passionate trainer, training 
staff in Mississippi and in other southeastern states 
when needed. She strives to make her trainings 
meaningful, accessible, and affordable, and has 
embraced the use of technology when it is 
appropriate. Her contributions to the general 
awareness of TB in Mississippi have been significant, 
including working with the legislature to issue a 
proclamation for World TB Day!   
 
Ed Desmond TB Laboratorian Award 
This award honors exemplary service, dedication, or 
leadership to a TB laboratory professional. The 2014 
winner of this award is Dr. David Warshauer. Dave 
serves as Deputy Director of the Communicable 
Disease Division for the Wisconsin State Laboratory 
of Hygiene (WSLH). He has generously shared his 
expertise regionally and nationally, serving on many 
national workgroups dedicated to the improvement of 
public health laboratory services. Specifically, Dave 
currently serves as Chair for the Association of Public 
Health Laboratories (APHL) TB Sub-Committee that 
works to shape the future of TB public health 
laboratory science, practice, and policy. As a member 
of an APHL taskforce, Dave was instrumental in 
updating Mycobacterium tuberculosis: Assessing 
Your Laboratory, a tool designed to assist 
laboratories in the assessment of the quality of their 
laboratory’s TB diagnostic practices.  
 
Through these significant time commitments and 
exchanges of knowledge, Dave is contributing to the 
control, prevention, and eventual elimination of TB in 
Wisconsin and nationally. Dave is not a one-man 
show; he encourages growth and expertise among 
his staff, and many of them are also nationally known 
in their areas of expertise. Development of new tests, 
validation of existing ones, and meticulous quality 
control are strong features of his laboratories. His 
close collaboration with state and local public health 
agencies ensures that joint guidance for appropriate 
testing and interpretation of results is always 
available, whether on an urgent basis for an unknown 
entity, or when providing routine testing.  
 
Joe Ware Partner Service Award 
This award recognizes an organization that has made 
a significant effort and/or contribution to the mission 
of TB control and prevention through partnership 
Dr. David Warshauer, left, received the NTCA’s Ed 
Desmond TB Laboratorian award. 
Ann Jackson (center) received the NTCA’s Carol 
Pozsik TB Nurse award. 
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activities with public health TB programs. The 2014 
winner is the Treatment Action Group (TAG).  
 
TAG works to promote the participation of affected 
communities in TB research and to ensure that 
research reflects community needs as well as 
scientific priorities. In addition to TAG’s work with TB 
patients and survivors, TAG coordinates two groups 
of research-literate community activists—the Global 
TB Community Advisory Board, and the Community 
Research Advisory Group (CRAG). CRAG is an 
advisory body to the U.S. Centers for Disease 
Control and Prevention’s Tuberculosis Trials 
Consortium (TBTC), the CDC-funded sites 
conducting TB clinical trials.  
 
During the past year, TAG has partnered with the 
NTCA to address multiple problems with ramifications 
for TB programs and the communities we serve. 
From convening the initial response in 2013 to the TB 
drug shortages, to their efforts to influence the pricing 
structure of rifapentine, TAG’s commitment to making 
a difference has resulted in monumental changes. 
The team’s ability to advocate extends to the written 
word: its staff members have successfully published 
numerous articles, letters to the editor, full-length 
reports, and opinion pieces involving TB research, 
program challenges, and the importance of engaging 
the community affected by the disease in the 
research work being conducted to address the 
disease. This small but amazingly talented team of 
creative, intelligent, and passionate persons is led by 
Mark Harrington and Colleen Daniels, Director of 
TAG’s TB-HIV project. 
 
NTCA is indeed fortunate to work alongside TAG and 
anticipate more opportunities for collaboration and 
partnership in the years to come!  
 
Dixie Snider Award 
This award recognizes a CDC employee who has 
provided outstanding support, through partnership 
with a state or a local TB community, in the interest of 
TB control and prevention. Kenneth Castro, MD, is 
the 2014 recipient of this prestigious award. Ken has 
served as the Director of DTBE for over 20 years but 
recently announced his retirement from the 
Commissioned Corps and his departure from the 
Division. While Ken came into the storm, he not only 
weathered it, he left the nation in far better shape. He 
is known to all in the TB community as a leader who 
has that great mixture of being humble, yet very 
bright. 
 
He stands for all things that we look for in a national 
leader. While supporting critical innovations and 
advancing needed TB tools, he also saw the value of 
shoe-leather epidemiology and investing in boots on 
the ground. He knew that TB transmission occurs, 
not in an office or in a government agency, but in the 
communities and states across the nation. That 
knowledge stimulated him to be accessible, to be a 
good listener, to carefully reflect as he tried to solve 
problems, and to care passionately about what was 
happening at each program. He sets a valuable 
example for the next leader of DTBE.  
 
Dr. Flood touched on Dr. Castro’s many 
characteristics and contributions that were 
considered when selecting him for the award, 
including the following: 
• He built bridges and established partnerships 
with every level of TB control, from global down 
to state and local. 
• He gave the TB community a voice. 
Dr. Kenneth Castro, center, received the Dixie 
Snider award. 
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• He was successful because he tried to achieve 
consensus and he was responsive to TB 
controllers and TB staff on the frontline. 
• Even if he was called at 5 pm California time, he 
was usually in his office, and picked up the 
phone after 8 pm Atlanta time.  
• He trusted and respected TB controllers. 
• He saw the lengthy 3HP trial through to 
completion—which we think is a game changer. 
• The current real-time genotyping of all TB strains 
he initiated in the country serves as a model to 
other public health programs. 
• The integration of the TB Laboratory Branch into 
DTBE generated synergies between program 
and laboratory that are exemplified by the great 
service provided by the molecular detection of 
drug resistance unit of the laboratory. 
 
Dr. Flood concluded her remarks about Dr. Castro by 
recognizing that “We know your heart and passion 
forever remain with TB. We thank you for your 
dedication to this fight!” 
 
President’s Award 
This award, given at the discretion of the President, 
recognizes the individual who, in the President’s 
opinion, exemplifies service and dedication to TB 
control efforts. This year’s President’s Award was 
given to Lorna Will, RN, MA, TB controller for the 
state of Wisconsin (no photo available; she was not 
at the conference). In Dr. Flood’s remarks about 
Lorna, she indicated that “What we love about Lorna 
and what makes her truly a great leader is that she is 
fearless in her efforts to speak the truth, both about 
TB and about what it takes to control TB, and then 
endeavors to make a difference—not just for 
Wisconsin, but for her neighbors and colleague 
states.” As the Wisconsin TB controller, she faced a 
large MDR outbreak and did what we are charged to 
do, but something that is hard: Lorna not only 
ensured that everyone with disease and exposure 
had the best chance for treatment, cure, and survival, 
she used this event to help the nation come to grips 
with the fact that even in a state like Wisconsin, TB is 
a very potent force that needs to be dealt with. While 
experiencing the economic consequences for 
Wisconsin, she made TB more compelling by 
calculating the expenses beyond the human illness 
and circulating this stunning cost for others to use in 
educational and advocacy-oriented efforts. 
 
Lorna is currently fighting another, more personal 
battle with cancer. The entire NTCA community 
extends our gratitude for, and support of, all that 
Lorna has contributed for TB control. We anxiously 
look forward to the time when we can welcome her 
back and continue our efforts together!  
 
Winners of the NTCA Poster Competition 
 
In addition to the annual awards, the NTCA 
recognized the top posters presented at the 2014 
conference. The judges decided to give only first-
place awards, selecting the top poster in various 
categories, since there were so many deserving 
poster submissions. Chosen from a record-high 
submission of 78 abstracts, the following five posters 
were singled out by the judges as being of the 
highest quality: 
 
Poster #1 – Programmatic category 
Presenter: Richard Brostrom, MD, MSPH 
Hawaii Department of Health 
Against All Odds: Early MDR-TB Treatment Success 
in the U.S. Pacific 
 
Co-authors: Dorina Fred, Sapna Bamrah, Mayleen 
Ekiek, Andy Heetderks, Richard Stapledon, and 
Sundari Mase. 
 
Poster # 13 – Clinicans/Physicians category 
Presenter: Scott Heysell, MD, MPH 
University of Virginia 
Second-line Drug Concentrations in Multidrug-
Resistant TB Patients Treated in Virginia, 2009–2014 
 
Co-authors: Jane Moore, Eric Houpt 
 
Poster # 14 – Research category 
Presenter: Suzanne Marks, MPH, MA 
Centers for Disease Control and Prevention 
Characteristics Associated with Hospitalization for 
Multidrug-Resistant TB Care in the United States 
 
Co-authors: Yael Hirsch-Moverman, Lori Armstrong, 
Edward A. Graviss, Peter Oh, Lisa Armitige, Katya 
Salcedo, Paul W. Colson, Sundari Mase, Barbara 
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Seaworth, Jennifer Flood, and the TB Epidemiologic 
Studies Consortium 
 
Poster # 21 – Nursing category 
Presenter: Catalina Navarro 
Heartland National TB Center 
Just-in-Time Training for TB Nurses 
 
Co-authors: Debbie Onofre, Jessica Quintero, Alysia 
Wayne, and Barbara Seaworth 
 
Poster # 59 – Laboratory category 
Presenter: William Murtaugh, MPH 
Association of Public Health Laboratories 
Evaluating the Impact of Molecular Diagnostics for 
TB within the Public Health Laboratory System. 
 
Co-author: Kelly Wroblewski 
 
NTCA is grateful for the interest in this year’s poster 
presentations and for the efforts of our team of 
judges who were dedicated to their task of reviewing 
all submissions and providing equal assessment of 
the merits of each! Judging occurred over lunch 
hours, pre- and post-conference hours, and during 
scheduled breaks. The judges for this year’s poster 
presentations were John Bernardo, Diana Nilsen, 
Michelle Macaraig, and Jennifer Curran. 
 
—Submitted by Donna Hope Wegener 
and Jennifer Kanouse 
National TB Controllers Association 
 
TB EPIDEMIOLOGIC STUDIES 
CONSORTIUM STUDIES UPDATES 
 
5th Annual Meeting of the TB 
Epidemiologic Studies Consortium 
(TBESC) II 
 
More than 11,000 persons at high risk for latent 
tuberculosis infection (LTBI) or TB disease have 
been enrolled during the first 3 years of a 10-year 
study to evaluate the performance characteristics and 
predictive value of three tests for LTBI, according to 
data presented at the 5th annual meeting of the 
Second Tuberculosis Epidemiologic Studies 
Consortium (TBESC-II), held July 29–30 at CDC’s 
Century Center campus in Atlanta. 
The study is being conducted at 10 sites across the 
United States; participants receive all three FDA-
approved tests for LTBI—the tuberculin skin test 
(TST), and two interferon-gamma release assay 
(IGRA) blood tests—and are followed actively and 
passively (i.e., with TB registry matches) to find 
persons whose M. tuberculosis infection progresses 
to TB disease. 
 
The meeting gathered 65 CDC and site principal 
investigators (PIs), project coordinators, other CDC 
researchers, and administrative staff to review study 
progress and to plan future sub-studies.  
 
Preliminary data presented at the meeting by Dr. 
Renuka Khurana, Maricopa County (AZ) PI, showed 
that- 
• high-risk persons are being enrolled, 
• persons positive on all three tests have other 
markers of high risk for TB infection, 
• agreement between TST and IGRAs are 
consistent with previous findings in the literature, 
and 
• agreement between the two IGRAs—the 
QuantiFERON-TB Gold In-Tube (QFT) and the 
T-SPOT.TB (T-Spot)—is lower than what has 
been reported in the literature. 
 
The analyses that are planned include the power of 
the tests to predict progression to TB disease; 
evaluation of IGRAs in special populations, including 
children and immunocompromised persons; 
determination of the cost-effectiveness of the three 
tests; and evaluation of the effects of various 
treatment regimens on completion of LTBI treatment. 
 
In other presentations at the meeting, project 
coordinators Yoseph Sorri of Maricopa County, 
Arizona, and Stephanie Bigby of Broward County, 
Florida, walked the audience through the complex 
steps of follow-up, including techniques for tracking 
difficult-to-find study participants. Dr. Edward 
Graviss, Director of the Molecular Tuberculosis 
Laboratory at the Methodist Hospital Research 
Institute in Houston, provided an overview of his 
quality assurance visits to the 12 laboratories that 
process QFT samples for the study. Dr. Graviss 
noted that differences in the ways the laboratories 
process specimens can produce variability in the 
 NUMBER 3, 2014 
10 
 
results. Dr. Adithya Cattamanchi of the Curry 
International Tuberculosis Center at University of 
California-San Francisco described additional small 
studies (e.g., IGRA variability and translational 
research) that Consortium members could do to 
enhance the Consortium’s research value. 
 
Researchers also laid out preliminary plans for sub-
studies that will be rolled out. Dr. Susan Dorman of 
Johns Hopkins University, Baltimore, presented plans 
for enhanced surveillance for LTBI at the 10 sites, 
using a model adapted from HIV and hepatitis 
surveillance and treatment. Called the TB care 
cascade, the enhanced surveillance would use 
Census and other data to (1) describe populations at 
high risk for TB and (2) determine the proportions of 
these populations at each site that are tested for 
LTBI, diagnosed, placed on treatment, and complete 
treatment. Combined with TB registry data, this sub-
study would indicate “hot spots” at the sites where 
high-risk persons either do not enter the care 
cascade or drop out of the cascade before treatment 
completion. This enhanced surveillance would also 
help lay the basis for the next sub-study: 
development and testing of interventions to improve 
LTBI treatment and TB prevention. 
 
—Reported by Dolly Katz, PhD 
Div of TB Elimination 
 
CLINICAL RESEARCH BRANCH 
UPDATES 
 
Retirement of Beverly DeVoe-Payton 
 
Beverly DeVoe-Payton, 
Deputy Director of DTBE’s 
Clinical Research Branch 
(CRB), retires August 29 
after 32 years of federal 
service, including 22 years 
of service for CDC. Her 
CDC career, which spanned 
a remarkable period in TB control, included 
responding to the resurgence in TB that affected the 
nation in the period 1985-1992, helping to rebuild and 
re-equip one of the busiest TB control programs in 
the United States, and later putting her substantial 
field and administrative skills to use in supporting the 
effort to develop new and better tools to address the 




Beverly grew up in Jacksonville, Florida, the eldest of 
three siblings. She graduated from Edwards Waters 
College with a Bachelor’s of Science degree in 1976. 
She then worked for the next 9 years for the U.S. 
Postal Service in various capacities, lastly as a retail 
sales window clerk.  
 
Then, while at college again in Atlanta in 1983, she 
attended Morris Brown College’s Career Day where 
she heard a presentation by a CDC epidemiologist 
about the extraordinary public health work of CDC.  It 
became her dream to work at CDC. At the time, 
although she was uncertain she could realize this 
goal, she began to work thoughtfully towards it. She 
returned to school, and earned a Master’s of Science 
in Health degree at the University of North Florida. 
In 1987 she was offered her first job in public health 
as a Health Representative for the Florida 
Department of Health in Naples. She gained 
experience first-hand as an outreach and DOT 
worker in the migrant worker camps in Immokalee. In 
Migrant workers in the field. 
Edward Waters College in Jacksonville, Florida. 
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1990 she began for the first time to work in 
tuberculosis prevention and control, when she was 
promoted to become the Florida District 2 (North 
Central) TB Program Manager in Tallahassee. 
 
 
In October of 1992, she realized the first of her goals, 
and was hired to work as a Public Health Advisor in 
the Division of Tuberculosis Field Services Branch. 
Her first posting was as TB Coordinator in the Fulton 
County Department of Health and 
Wellness in Atlanta. The city, like the 
nation, was then experiencing the 
effects of the national resurgence in 
TB due to the impacts of HIV, 
congregate living facilities, and years 
of program neglect. Beverly says she 
found the work fascinating and 
satisfying, working with others in 
public health at the local level, 
getting to know and care for the 
patients, witnessing the impact of 
tuberculosis on the lives of the 
program’s patients, and providing 
guidance on contact investigation to outreach 
workers based on her experience as a local health 
department outreach worker in Florida.  
 
In 1994 she was promoted to become Atlanta’s Metro 
TB Coordinator, working in the Division of Public 
Health at the Georgia Department of Human 
Resources. In 1995 she was named TB Program 
Manager for the state of Georgia; she held this post 
for 14 years, beginning and solidifying state-wide 
improvements in TB prevention and control. There 
she worked with and influenced a series of capable 
colleagues, including Katherine Toomey, Roger 
Schilling, Naomi Bock, Michael Leonard, Rose Sales, 
and Andy Vernon. 
 
During her last 5 years with CDC, she has served as 
Deputy Branch Chief of DTBE’s CRB. She relates 
that it was hard for her to move away from 
programmatic work and service with state and county 
Health Departments. However, she says that she had 
come to understand the vital role of research in the 
effort to reach the goal of TB Elimination, and wanted 
to contribute in this area as well. She joined CRB in 
2009, just as the TB Trials Consortium contracts 
were undergoing re-competition, and was 
immediately called on to play a substantive role in 
that process. As before, despite trepidation and 
uncertainty, she took on new responsibility with 
enthusiasm, diligence, and courage. Over the past 5 
years, she has become the “rock” of the Branch, the 
person to whom everyone turns for help. Her 
judgment, ability, fairness, and integrity are widely 
respected, and the remaining Branch leadership will 
deeply miss her guidance and support. 
Throughout her years with CDC, Beverly has 
demonstrated steadiness of vision, commitment to 
public health, and courage to address new 
challenges, which have won the admiration and 
loyalty of her colleagues at all levels. She has been a 
consistently welcome presence in every group and 
effort, and her loss will be keenly felt by those who 
are fortunate enough to have called her friend and 
colleague. 
 
—Reported by Andrew Vernon, MD, MHS 
Div of TB Elimination 
Beverly, back row, far left, with her CRB colleagues in 2009. 




AND BEHAVIORAL STUDIES 
BRANCH UPDATES 
 
Revised Self-Study Modules on 
Tuberculosis, 6–9 
 
To meet the goal of 
TB elimination, it is 
essential that health 
care workers receive 
education and training 
on current TB control 
and prevention 
strategies. To 
address this need, the 
Self-Study Modules 
on Tuberculosis, 6–9 
were developed in 
1999 to provide 
programmatic TB 
information for health care workers, including 
outreach workers, nurses, physicians, and health 
educators in an easy-to-understand, self-study 
format. Modules 6–9 are an accompaniment to 
Modules 1–5, which provide basic information on TB. 
These booklets have served as an important 
resource in training new TB control workers. Over the 
years, however, the body of knowledge and the 
literature about TB patient management, public 
health practice, contact investigations, and other 
aspects of TB control has evolved.  
 
To ensure that new TB control workers have access 
to the most accurate and up-to-date information 
about TB control, Modules 6–9 were updated to 
reflect current practices and guidelines. Additionally, 
there is now a new module on TB outbreak detection 
and response. The Modules also have a fresh look 
and feel, with new graphics and layout.  
 
The Modules 6–9 package includes an introduction, 
four modules, and a glossary: 
• Introduction 
• Module 6: Managing Tuberculosis Patients and 
Improving Adherence 
• Module 7: Patient Rights and Confidentiality in 
Tuberculosis Control 
• Module 8: Contact Investigations for 
Tuberculosis  




To view the modules online, visit the DTBE website 
at www.cdc.gov/tb/education/ssmodules/default.htm.  
 
To order hardcopies of the modules, visit the CDC 
online ordering system at 
http://wwwn.cdc.gov/pubs/CDCInfoOnDemand.aspx.  
 
Continuing education is offered free of charge for 
various professions. For more information on 




If you have questions about the updated Modules 6–
9, please contact Sarah Segerlind at 
ssegerlind@cdc.gov. 
 
—Reported by Sarah Segerlind, MPH 
Div of TB Elimination 
 
INTERNATIONAL RESEARCH AND 
PROGRAMS BRANCH UPDATES 
 
Improving Diagnosis of TB Among 
People Living with HIV/AIDS 
 
In the past 5 years, CDC’s DTBE has provided critical 
technical support to Ministries of Health in nearly 40 
countries on surveillance and epidemiology, guideline 
development, capacity building, infection control, and 
laboratory strengthening. DTBE also conducts clinical 
and operational research to improve implementation 
of traditional TB control strategies for TB, TB/HIV, 
and MDR TB and evaluate promising new 
approaches. DTBE’s work has led to national and 
international policy change five times in as many 
years by following this approach.   
 
One such change arose from a multicountry study in 
Southeast Asia to determine the best approach for 
diagnosing TB among people living with HIV/AIDS 
(PLHA). The study developed a screening approach 
using routine diagnostics that could find nearly all 
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(93%) TB cases among PLHA compared to the 
approach at that time, which detected only 34%. 
These findings ultimately changed national guidelines 
in Cambodia in 2010 and informed World Health 
Organization (WHO) guidelines in 2011. This study 
has also spurred several follow-up studies in 
Cambodia, Vietnam, and Kenya to evaluate the 
performance of this algorithm in programmatic 
settings while incorporating new diagnostics, such as 
Xpert MTB/RIF® (Xpert).  
 
In Cambodia, DTBE is evaluating the implementation 
of the screening algorithm when paired with use of 
Xpert in four high TB burden provinces in Northwest 
Cambodia. This evaluation will be the first to follow 
patients eligible for Xpert from initial screening to 
treatment outcome using routinely collected national 
data to assess the impact and cost-effectiveness of 
the new algorithm. Early analysis has indicated that 
the screening algorithm is being routinely followed, 
but use of Xpert for those patients has been lower 
than expected because of health systems issues, 
such as patient referral, specimen transport, and 
results reporting.  
 
In Vietnam, DTBE is evaluating the implementation 
and performance of the screening algorithm in four 
HIV clinics in two cities. Unlike the initial study in 
Southeast Asia, the follow-up project in Vietnam aims 
to evaluate the diagnostic yield and outcomes of 
those screened not only at their enrollment into HIV 
care, but also at their subsequent clinical encounters 
throughout HIV care. Preliminary analyses revealed a 
prevalence of TB among PLHA nearly 57 times 
greater than among the general population. 
Preliminary data also suggest that repeated 
screening for TB may be useful not only in 
diagnosing TB, but also in ruling out active TB 
disease and initiating TB preventive therapy in 
eligible patients.  
 
In Kenya, DTBE is replicating the study from 
Southeast Asia to better understand its impact in a 
high HIV burden setting. The site in Kenya is also 
including children with HIV/AIDS to explore the best 
approach for screening and diagnosing TB in this 
vulnerable population. Many children with TB have 
clinical findings different from adults, making it more 
challenging to determine which children are at risk for 
TB. More challenging still, collecting specimens from 
children for traditional diagnostics like smear 
microscopy and culture can be difficult, resulting in 
diagnosis of only a fraction of cases (15%–30% of 
cases). This study seeks to determine better ways to 
diagnose TB among children to address this critical 
gap. 
 
DTBE will continue to conduct programmatically 
relevant research to build the global evidence base 
for new strategies, translate those findings into 
practice, and scale up evidence-based approaches 
through technical assistance and training with our 
partners. 
 
—Submitted by Brittany Moore, MPH, 
and Tori Cowger, MPH 
Div of TB Elimination 
 
SURVEILLANCE, EPIDEMIOLOGY, 
& OUTBREAK INVESTIGATIONS 
BRANCH UPDATES 
 
The Only Thing That Is Constant 
Is Change: DTBE’s Annual TB 
Surveillance Report, 1993–2013 
 
The United States national tuberculosis (TB) program 
has reported nationally representative aggregate TB 
disease data since report-year 1952; however, case-
based reporting of TB was implemented in 1979, with 
recruitment of reporting areas being completed in 
1985. The Report of Verified Case of Tuberculosis, or 
RVCT, became the electronically submitted standard 
data form in 1993. The first annual report of 
surveillance based on this electronically reported 
data, which was hereafter referred to as the National 
Tuberculosis Surveillance System (NTSS), was 
published in 1994,1 reporting 1993 data. Every year 
since then, the national TB program has released an 
annual surveillance report containing comprehensive 
tables and figures that are widely used internally at 
CDC and externally by reporting jurisdictions and 
other national and international partners. The report 
has become an example of the ability of CDC to 
create and publish a quality surveillance report based 
on recently reported data. In fact, the report is 
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published within 10 months of the completion of each 
calendar year. 
 
The 2013 report scheduled for publication in 
September 2014 will bear little resemblance to the 
1993 report. The 1993 report was a very slim, staple-
bound booklet, containing 27 tables and seven 
figures. It was not released on the Internet, and the 
physical print number is virtually unknown. It had only 
one trend table, containing case counts, and 
morbidity and mortality rates dating back to 1953. 
The remainder of the tables displayed 1993 TB data 
by state or metropolitan statistical area. While it had 
information on selected social factors, drug 
resistance, HIV status, race/ethnicity, and origin of 
birth, it had no data on completion of therapy, drug 
regimen, genotyping, reason therapy was stopped, or 
risk factors for development of TB disease. The entire 
1993 report was only 42 pages long. 
 
The 2013 report will have 67 tables and 36 slides 
providing figures. It will also contain explanatory 
footnotes, appendices, an executive commentary, 
and a robust technical notes section to aid with 
interpretation. Although a small number of 2013 
reports will be printed (about 200 copies), this report 
will be primarily available as a digital document on 
www.CDC.gov/tb; this inversion of the publication 
process saves tens of thousands of dollars, speeds 
up release time, and enables the report to reach 
many more users. The 2013 report will also be 
searchable and downloadable. Compared to 1993, 
the upcoming report will have trend tables reflecting 
the past 20 years of NTSS data, as well as in-depth 
data provided on genotypic clustering, epidemiologic 
characteristic analyses, breakdown of correctional 
facility information, death data, M. bovis case counts, 
reason for TB evaluation, therapy extension… the list 
goes on and on. The entire report is 186 pages long, 
representing a 343% increase in pages from the 
1993 document. 
 
—Reported by Carla Jeffries, JD, MPH 
Div of TB Elimination 
 
Reference 
1. CDC. Reported Tuberculosis in the United States, 
1993. Atlanta, GA: U.S. Department of Health and 
Human Services, CDC, 1994. 
  
NEW CDC PUBLICATIONS 
 
Bamrah S, Brostrom R, Dorina F, Setik L, Song R, 
Kawamura LM, Heetderks A, Mase S. Treatment for 
LTBI in contacts of MDR-TB patients, Federated 
States of Micronesia, 2009–2012. Int J Tuberc Lung 
Dis 2014 18(8):912–918. 
http://dx.doi.org/10.5588/ijtld.13.0028. 
Cegielski JP, Dalton T, Yagui M, Wattanaamornkiet 
W, Volchenkov GV, Via LE, Van Der Walt M, Tupasi 
T, Smith SE, Odendaal R, Leimane V, Kvasnovsky C, 
Kuznetsova T, Kurbatova E, Kummik T, Kuksa L, 
Kliiman K, Kiryanova EV, Kim H, Kim CK, Kazennyy 
BY, Jou R, Huang WL, Ershova J, Erokhin VV, Diem 
L, Contreras C, Cho SN, Chernousova LN, Chen MP, 
Caoili JC, Bayona J, Akksilp S; the Global PETTS 
Investigators. Extensive drug resistance acquired 
during treatment of multidrug-resistant tuberculosis. 
Clin Infect Dis. 2014 Jul 23. pii: ciu572. [Epub ahead 
of print.] 
 
Davis JL, LM, Chaisson LH, Grinsdale J, 
Benhammou J, Ho C, Babst A, Banouvong H, 
Metcalfe JZ, Pandori M, Hopewell PC, Cattamanchi 
A. Impact of GeneXpert MTB/RIF on patients and 
tuberculosis programs in a low-burden setting. A 
hypothetical trial. Am J Respir Crit Care Med 2014; 
189 (12):1551–1559. doi: 10.1164/rccm.201311-
1974OC . 
 
Defang RR, Brostrom R, Ram S, Johnson E, Perman 
PS. Screening for tuberculosis and LTBI in diabetes 
patients, Pohnpei, Federated States of Micronesia. 
Public Health Action 2014 June 21; 4 (Suppl 1): S53–
S55. 
 
Duraisamy K, Mrithyunjayan S, Ghosh S, Nair SA, 
Balakrishnan S, Subramoniapillai J, Oeltmann JE, 
Moonan PK, Kumar AM. Does alcohol consumption 
during multidrug-resistant tuberculosis treatment 
affect outcome? A population-based study in Kerala, 
India. Ann Am Thorac Soc. 2014 Jun;11(5):712–8. 
 
Nasa JN, Brostrom R, Ram S, Kumar AM, Seremai J, 
Hauma M, Paul IA, Langidrik JR. Screening adult 
tuberculosis patients for diabetes mellitus in Ebeye, 
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Republic of the Marshall Islands. Public Health Action 
2014 June 21; 4 (Suppl 1): S50–S52. 
 
Pascopella L, Franks J, Marks SM, Salcedo K, 
Schmitz K, Colson PW, Hirsch-Moverman Y, Flood J, 
Sayles J. Opportunities for tuberculosis diagnosis 
and prevention among persons living with HIV: a 
cross-sectional study of policies and practices at four 
large Ryan White program-funded HIV clinics. PLoS 
One. 2014 Jul 7;9(7):e101313. doi: 
10.1371/journal.pone.0101313. eCollection 2014. 
 
Podewils LJ, Alexy E, Driver SJ, Cheek JE, Holman 
RC, Haberling D, Brett M, McCray E, Redd JT. 
Understanding the burden of tuberculosis among 
American Indians/Alaska Natives in the U.S.: a 
validation study. Public Health Rep. 2014 
Jul;129(4):351–60. 
 
Shivaramakrishna HR, Frederick A, Shazia A, Murali 
L, Satyanarayana S, Nair SA, Kumar AM, Moonan 
PK. Isoniazid preventive treatment in children in two 
districts of South India: does practice follow policy? 
Int J Tuberc Lung Dis 2014 August 1; 18(8):919–924. 
http://dx.doi.org/10.5588/ijtld.14.0072. 
 
Suryaprasad A, Redd JT, Ricks PM, Podewils LJ, 
Brett M, Oski J, Minenna W, Armao F, Vize BJ, 
Cheek JE. Effect of rapid influenza diagnostic testing 
on antiviral treatment decisions for patients with 
influenza-like illness: southwestern U.S, May-
December 2009. Public Health Rep 2014 
Jul;129(4):322–7. 
 
Yuen CM, Weyenga HO, Kim AA, Malika T, Muttai H, 
Katana A, Nganga L, Cain KP, De Cock KM. 
Comparison of trends in tuberculosis incidence 
among adults living with HIV and adults without HIV 
— Kenya, 1998–2012. PLoS One. 2014 Jun 





Negar (Niki) Alami, MD, has left IRPB and DTBE 
after completing 2 years as an Epidemic Intelligence 
Service (EIS) officer in June 2014. During her time 
with DTBE, Niki participated in many projects, 
including evaluations of the national TB surveillance 
systems in Botswana and Kenya, assessment of 
community-based programmatic management of 
drug-resistant TB in Bangladesh, analysis of the 
diagnostic value of urine mycobacterial culture for 
people living with HIV, investigation of outbreaks 
caused by M. tuberculosis in the U.S, and validation 
of a new TB molecular diagnostic test in Thailand. 
She also lectured on epidemiology and use of 
statistical software at the Research Institute of 
Tuberculosis in Japan. She somehow made the time 
to participate in other CDC efforts, and she helped 
investigate the multistate outbreak of fungal 
meningitis among patients who received 
contaminated steroid injections, served as a UNICEF 
Health Adviser in the Syrian refugee crisis, and 
investigated the epidemiology and transmission of 
Middle East Respiratory Syndrome (MERS) caused 
by a novel coronavirus called MERS-coV.  
 
Niki is currently an associate medical director at 
AbbVie Laboratories where she strives to combine 
her clinical, infectious disease, and pubic health 
knowledge to influence patient care and public 
health. The branch anticipates great things from her 
and is learning to get along without her Persian 
panache and inextinguishable cheer.  
 
Bruce Bradley, MPA, Senior PHA, was assigned to 
FSEB on July 27, 2014, where he will serve as a 
Program Consultant. Bruce started his career with 
CDC/DTBE in 2002 as a Public Health Analyst in the 
Data Management and Statistics Branch; in addition, 
he served as the Technical Contact for the CITS II 
contract and as the TIMS trainer. He was 
instrumental in assisting national TB programs with 
the transition from TIMS to the National Electronic 
Disease Surveillance System (NEDSS). He was also 
one of the TB subject matter experts for the 
development and design of the NEDSS Base System 
(NBS) TB Program Area Module (TB PAM) and the 
eRVCT. Bruce served from 1993 to 1997 as a 
regional TB program coordinator in the state of 
Georgia. 
 
In July 2009, Bruce accepted a position with FSEB as 
the TB Program Manager for Fulton County, Georgia. 
In his position he managed the TB Program and 
helped lead the screening of homeless shelters in 
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Fulton County. He was instrumental in helping to 
implement the 3HP treatment for LTBI in the county 
and to improve the LTBI completion rate. He also 
served as co-project coordinator for other CDC-
funded initiatives and projects (such as the House 
Ball Community). 
 
In June 2013, Bruce was assigned to the State of 
Georgia TB Program as a Senior PHA. In this 
position, Bruce was the liaison for the TB 
Coordinators in the State of Georgia where he 
reviewed and analyzed the quarterly reports, 
budgets, and contracts of each health district. Bruce 
was also in charge of the genotyping database for the 
State of Georgia and assisted with the TB outbreak in 
Fulton County. 
 
Bruce holds a Master of Public Administration degree 
from Georgia College and State University and 
earned a Graduate Certificate in Epidemiology from 
the Tulane School of Public Health and Tropical 
Medicine. 
 
Simone Butler has joined DTBE as an administrative 
assistant. She was initially assigned to the Office of 
the Director, where she provided administrative 
support for DTBE/OD. She then was re-assigned to 
FSEB, where she will be providing administrative 
support for Dr. Terry Chorba, Mr. Glen Christie, and 
the medical team here at DTBE headquarters. 
 
Simone is a native of Boston, and attended 
Northeastern University. She has lived in Atlanta for 
the past 14 years. Simone has previously worked at 
CDC, and is looking forward to working with DTBE. 
 
Tori Cowger, MPH, joined the TB/HIV Team with the 
International Research and Programs Branch on 
June 30, 2014. She was recruited to provide 
epidemiological and programmatic support for our 
portfolio of USAID-supported childhood TB activities. 
Tori has previous experience working at the state, 
federal, and international program level, having 
interned at the Georgia Department of Public Health’s 
Emerging Infections Program, at CDC’s Bioterrorism 
Rapid Response and Advanced Technology Lab, at 
CDC’s Epidemiology & Laboratory Capacity Program 
in American Samoa, and most recently as a research 
fellow with the TB/HIV Team of IRPB. Tori earned her 
MPH from the Epidemiology Department of the 
Rollins School of Public Health at Emory University 
and her Bachelors in Science in Biochemistry from 
the University of Minnesota. 
 
Justin Davis, an ORISE fellow, is working with Ann 
Cronin in DTBE/OD on policy and issues 
management until March 2015. Justin joined 
DTBE/OD in May 2014 from the Office of the 
Associate Director for Policy, Office of Health System 
Collaboration, where he worked the previous 14 
months with the team responsible for developing 
CDC’s public health-health-care collaboration 
strategy. In this capacity, he focused on multiple 
projects exploring health reform–related opportunities 
for public health and the clinical and social services 
sectors to partner to improve health at the population 
level. Previously, Justin worked in marketing and 
community education in the field of hospice. Filling 
roles such as provider relations manager and director 
of professional relations, he focused on building 
referral partnerships, while working alongside 
physicians, hospitals, and long-term care and 
assisted living facilities. He received his BBA from 
Emory University’s Goizueta Business School in 
2004 and is a 2012 MPH graduate of Georgia State 
University’s School of Public Health.  
 
Beverly DeVoe-Payton, MS, retires August 29 after 
32 years of federal service, including 22 years of 
service with CDC. She helped rebuild and re-equip 
one of the busiest TB control programs in the United 
States, and later put her substantial field and 
administrative skills to use in support of DTBE’s 
efforts to develop new and better tools to address the 
TB epidemic, through her work as a leader in DTBE’s 
Clinical Research Branch. Please see the tribute to 
Beverly in the Clinical Research Branch Updates 
section of this issue. 
 
Bridgette Dunlap Simmons, MPH, has been hired as 
a Public Health Advisor in DTBE's Field Services and 
Evaluation Branch. Her current assignment is with 
the City of Houston TB control program, where she 
works with colleagues to maintain adherence to 
treatment. 
 
In July 2012, she began employment with CDC 
through the Public Health Associate Program 
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(PHAP). Her assignment started with the Office of 
State, Tribal, Local, and Territorial Support 
(OSTLTS), where she was assigned to the 
Mississippi State Department of Health (MSDH) as a 
Disease Intervention Specialist. As a member of the 
Tuberculosis Division, her work involved protecting 
the community from TB infection and disease by 
helping provide directly observed therapy (DOT), 
targeted testing, contact investigations, and health 
promotion. Other duties included program 
development, evaluation, and health education. While 
assigned to MSDH she collaborated with colleagues 
on multiple TB outbreaks throughout Jackson Public 
School (JPS) District. 
 
Before joining PHAP, Bridgette interned with the 
Central Alabama Veterans Health Care System, 
Veteran Health and Preventive Education, located in 
Montgomery, Alabama. She assisted with the 
Smoking Cessation and MOVE programs by 
providing health promotion, health education, and 
nutrition counseling. Bridgette received her graduate 
degree in 2012 from Florida International University 
with a Master’s degree in Public Health with a focus 
on Health Promotion and Disease Prevention. 
 
Denise Garrett has left DTBE to join the President’s 
Malaria Initiative; her last day with DTBE was August 
8. She has been selected to be the Resident Advisor 
in Angola. This position is with CDC’s Center for 
Global Health (CGH) in the Division of Parasitic 
Diseases & Malaria. It is an Atlanta position, meaning 
that she will be able to return to Atlanta frequently, 
but she will physically be based in Luanda, Angola. 
She is excited about the opportunity to make an 
important contribution to such an important problem 
in Africa. 
 
Denise was born in Brazil, where she received her 
medical degree in 1986 and a master’s degree in 
science in 1991. Denise joined CDC in 1993 as a 
researcher in the former Division of Parasitic 
Diseases (DPD) / National Center for Infectious 
Diseases. In 1996, she became an Epidemic 
Intelligence Service (EIS) Officer with the Division of 
Healthcare Quality Promotion (DHQP), in the then-
Hospital Infections Program. Following EIS, Denise 
was hired as a Medical Epidemiologist by DHQP, 
where she coordinated and implemented several 
studies on TB among health care workers. In 2000, 
she took a position with the former Division of 
International Health (DIH) / Epidemiology Program 
Office (EPO), as a CDC consultant for the Field 
Epidemiology Training Program (FETP) in Brazil. 
From 2002 to July 2007, Denise worked as a CDC / 
U.S. Agency for International Development (USAID) 
consultant to the Brazilian National TB Program 
(NTP). Her responsibilities included providing 
epidemiologic advice, consultation, and training on 
TB; implementation and strengthening of TB control; 
and conducting operations research on the diagnosis, 
treatment, and management of TB, TB/HIV, and 
MDR TB in Brazil. In 2007, Denise worked as a 
Westat contractor on various Tuberculosis 
Epidemiologic Studies Consortium (TBESC) 
activities, including Task Order #18. In August 2008, 
Denise was promoted to the position of Epidemiology 
Team Lead in SEOIB and Principal Investigator for 
the TBESC.  
 
Jamiee Gomez has joined DTBE as a Public Health 
Advisor working with the Los Angeles County TB 
Control Program. Prior to joining DTBE, she was an 
Associate in the Public Health Associate Program 
(PHAP) and was assigned to the Texas Department 
of State Health Services in San Antonio, TX. During 
that time, she served as a Disease Intervention 
Specialist for the HIV/STD program, where she 
focused on building relationships through case 
management. Her second year focused on patient 
care management through directly observed therapy 
for the TB department. Prior to joining CDC, she was 
a student at Dickinson College in Carlisle, PA, and 
graduated with a Bachelor of Arts degree in 
Anthropology with a concentration in global health in 
eastern Africa and the Caribbean. 
 
Steve Kammerer, MBA, joined the Molecular 
Epidemiology Activity team of the Surveillance, 
Epidemiology, and Outbreak Investigations Branch 
on July 14, 2014. Steve has been with the Division as 
a Northrop Grumman contractor since 2001, when he 
began assisting with the completion of the NTGSN 
genotyping pilot project. As the National Tuberculosis 
Genotyping Service was rolled out, Steve worked as 
the data manager for the new service, and 
participated in the design and implementation of TB 
GIMS. He has also worked to develop new methods 
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for outbreak detection using genotyping and 
surveillance data. Steve earned his Bachelor of 
Science degree with a major in Mathematics from the 
College of William and Mary, and a Master of 
Business Administration degree with a concentration 
in finance from Virginia Tech. 
 
Hannah Kirking, MD, has joined IRPB as one of the 
new EIS officers. Hannah completed her 
undergraduate studies at the University of Wisconsin-
Madison, and after working as a biomedical 
engineering for GE Healthcare Technologies, she 
studied international health and human rights at the 
University of Oslo. She later returned to the 
University of Wisconsin School of Medicine and 
Public Health to complete her medical degree. During 
medical school, Hannah spent a year working with 
CDC’s Division of Global Migration and Quarantine, 
during which time she worked on border health 
issues. Hannah completed a combined residency in 
internal medicine and pediatrics in Salt Lake City, 
Utah. While in Salt Lake City, Hannah worked with 
the International Rescue Committee (IRC) to improve 
refugee health through educational classes and 
improving access to care. Throughout her training, 
she has done international clinical work in India and 
Kenya as well as public health work with a local NGO 
in Honduras and with Relief International in 
Myanmar. 
 
Chris Lewis has recently arrived in DTBE and 
CEBSB, joining Chitvan Yadav as a webmaster. He 
is originally from Tennessee and attended Austin 
Peay State University in Clarksville, TN, graduating 
with a BFA in Graphic Design. He began his career in 
print design, transitioning over the last 6 years into 
web design. After working for 12 years in the 
corporate world, he joined CDC, where he has 
worked for the last 3 years. He has had assignments 
in CDC's Human Capital and Resources 
Management Office (HCRMO) and in the Laboratory 
Science, Policy, and Practice Program Office 
(LSPPPO). 
 
Phil LoBue, MD, has been selected as Director of 
DTBE. He began his CDC career in 1999 as a Field 
Medical Officer and an Epidemiologist assigned to 
the San Diego County TB Control Program. In 2004, 
he moved to Atlanta to become Chief of the Medical 
Consultation Team in the Field Services and 
Evaluation Branch of DTBE. Since 2006, he has held 
the position of Associate Director for Science for the 
Division. He has been honored to receive the CDC 
Honor Award for Excellence in Surveillance and 
Health Monitoring and the U.S. Food and Drug 
Administration’s Award for Outstanding Service. 
 
He earned both his undergraduate degree and his 
medical degree from the University of Pennsylvania. 
He completed a pulmonary and critical care 
fellowship in 1995 at the University of California (UC) 
San Diego Medical Center. He also served as an 
Assistant Clinical Professor of Medicine at UC San 
Diego. He is board certified in pulmonary medicine 
and critical care medicine. He is a member of the 
International Union Against Tuberculosis and Lung 
Disease, the American Thoracic Society, and several 
World Health Organization committees and working 
groups. 
 
Captain William R. Mac Kenzie, USPHS, Supervisory 
Medical Officer and Team Lead within the Clinical 
Research Branch (CRB), has been selected as the 
Center for Surveillance, Epidemiology and Laboratory 
Services (CSELS) Deputy Director for Science. He 
joins CSELS in September. 
 
Bill has a distinguished career at CDC and in serving 
state and local public health organizations. He led the 
design, oversight, management, and analysis of 
studies on the treatment of drug-susceptible and 
drug-resistant TB, and he collaborated with 
investigators at international and domestic academic 
centers, local TB programs, and the National 
Institutes of Health. In the face of fiscal and global 
public health challenges, Bill helped guide the future 
direction of the CRB and substantially influenced that 
of DTBE through his work as a member of the DTBE 
Think Tank, a group tasked by the DTBE Director to 
offer creative, concrete recommendations for cross-
cutting activities to carry out DTBE’s mission over the 
coming years. 
 
Before joining NCHHSTP, Bill served as an EIS 
Officer assigned to the Wisconsin Division of Health, 
Supervisory Medical Officer in the Division of Field 
Services, Epidemiology Program Office (a forerunner 
of CSELS), Supervisory Medical Officer in the 
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Division of Parasitic Diseases, and Quarantine 
Medical Officer assigned to the Los Angeles 
International Airport for DGMQ. In these varying 
roles, he led the investigation of the largest 
documented outbreak of waterborne disease 
associated with a public water supply 
(cryptosporidiosis in Milwaukee, Wisconsin), 
supervised and trained over 30 EIS officers who are 
now in leadership positions throughout the agency, 
and engaged in emergency preparedness and 
response planning for circumstances that would 
require coordinated emergency response to breaches 
in health security. 
 
Bill has substantial international public health 
experience including work with the International 
Rescue Committee in Kosovo. There, in collaboration 
with local officials and WHO, he led in the initial re-
building of the public health system through instituting 
syndromic surveillance for infectious diseases of 
public health importance and providing training for 
outbreak investigation and response.  
 
Bill received his medical degree from the University 
of California, San Francisco, trained in internal 
medicine and pediatrics at the University of Arkansas 
for Medical Sciences, and completed a fellowship in 
infectious diseases at Stanford University. He is a 
past winner of both the Alexander D. Langmuir Award 
and the Philip S. Brachman Award.  
 
Eugene McCray, MD, Chief of the International 
Research and Programs Branch (IRPB), was 
selected to serve as the Director of the Division of 
HIV/AIDS Prevention (DHAP) in NCHHSTP 
beginning August 11, 2014. 
 
Dr. McCray will bring many years of domestic and 
global experience in HIV and TB prevention and 
control to his work in DHAP. He began his career at 
CDC in 1983 as an Epidemic Intelligence Service 
Officer and has since served in a number of 
capacities throughout CDC. He was instrumental in 
CDC’s efforts from the early years of the HIV/AIDS 
epidemic and in 2000 he helped stand up and then 
lead CDC’s Global AIDS Program.  
 
Prior to his position as the Chief of IRPB, Dr. McCray 
was the Acting Deputy Director in CDC's 
Coordinating Office for Global Health from 2004 to 
2007 and Director of CDC’s Global AIDS Program 
from 2000 to 2004. In these positions, Dr. McCray 
directed and developed epidemiological, 
programmatic, and research activities, as well as 
facilitated collaboration across CDC, with other US 
government agencies, with multilateral and 
international agencies, and with Ministries of Health. 
He is recognized globally as an expert in HIV/AIDS 
and TB and has dedicated his career to improving the 
health of underserved communities both in the United 
States and globally. 
 
Dr. McCray completed his clinical training in internal 
medicine at North Carolina Memorial Hospital, 
University of North Carolina-Chapel Hill in 1983 and 
an Infectious Diseases Fellowship in 1992 at the 
University of Washington Medical Center, Seattle, 
Washington. He has authored or co-authored more 
than 60 scholarly articles and has received numerous 
awards for his scientific and public health 
contributions, including the US Public Health 
Service’s highest honor award, the PHS 
Distinguished Service Medal, and CDC’s William C. 
Watson Medal of Excellence award. 
 
Godwin Mindra, MD, MPH, has joined SEOIB as one 
of DTBE’s new EIS officers. He comes to CDC from 
the UNICEF South Sudan Country Office. In his role 
as a health specialist for the last 7 years, he worked 
to develop lasting health and nutrition policies for a 
population estimated at 10 million (as of 2013), with a 
specific focus on developing strategies to provide 
women and children with critical immunization 
services and nutritional interventions. Prior to joining 
UNICEF, Godwin worked with the government of 
Uganda as a clinician, and with the World Health 
Organization in northern Kenya. He helped establish 
the Early Warning Alert Response Network 
(EWARN), which allowed detection of outbreak-prone 
diseases in Southern Sudan and part of northern 
Kenya. This network has since developed into a fully-
fledged Integrated Disease Response and 
Surveillance (IDRS) system in South Sudan. He 
received his degree in medicine from Makerere 
University in Kampala, Uganda, and was awarded 
the prestigious Complex Humanitarian Emergency 
(CHE) fellowship, in addition to earning an MPH from 
Rollins School of Public Health in 2012. He co-
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authored an MMWR article in February 2012 on 
“Nodding Syndrome Investigation in South Sudan” 
and has a working document on “The Burden of 
Tuberculosis in Populations Affected by 
Emergencies.” 
 
Chimeremma (Chime) Nnadi MD, PhD, has 
completed the Epidemic Intelligence Service program 
with DTBE’s International Research and Programs 
Branch. While at DTBE, Chime provided assistance 
with TB outbreak and surveillance investigations in a 
number of domestic and international settings. In 
addition, Chime led the analyses of sundry studies, 
including the comparative analyses of trends in 
tuberculosis incidence between the United States 
and the United Kingdom and community and 
hospital-associated risk of tuberculosis in Kenya, as 
well as an evaluation of the diagnosis of tuberculosis 
among people living with HIV using lymph node 
aspirates. Never really adapting to life in the colonies, 
Chime accomplished most of these analyses during 
his preferred working hours of 1 to 4 a.m., and 
presented all of it in impeccable King’s English. 
Chime will be transitioning to a position with the 
Global Immunization Division, where he will be 
providing assistance with strengthening global 
vaccine systems. 
 
Eric Pevzner, PhD, has agreed to serve as Acting 
Chief, International Research and Programs Branch 
(IRPB), DTBE. Eric is a Behavioral Epidemiologist 
and the Team Lead for the TB/HIV team with IRPB.  
Since joining DTBE as an Epidemic Intelligence 
Service Officer in 2005, he has worked internationally 
to support the design and implementation of policies, 
programs, and studies to address the TB and HIV 
syndemic. During his public health career, Eric has 
worked at the international, national, state, and local 
levels focusing on TB control, HIV prevention, 
tobacco use prevention and control, cardiovascular 
disease prevention and rehabilitation, cancer 
prevention and control, and community health.  He 
earned his PhD in Health Behavior and Health 
Education and a minor in Epidemiology from the 
School of Public Health at the University of North 
Carolina at Chapel Hill in 2005, an MPH in Behavioral 
Science from the Rollins School of Public Health at 
Emory University in 1998, and a B.S. in Psychology 
from Michigan State University in 1995. 
 
Sandy Price joined the TB Information Systems 
Team of the Data Management and Statistics Branch 
on June 30, 2014. Sandy has been with the Division 
as a Northrop Grumman contractor since 1999, when 
she began supporting the TIMS project. As the 
National Tuberculosis Surveillance System 
transitioned from TIMS to NEDSS, Sandy worked to 
design and create the TB Data Warehouse as the 
Division’s repository for the TB surveillance data. She 
has also worked to improve the analysis, quality, and 
dissemination of TB surveillance data, both within the 
Division and with our state TB partners. Sandy 
earned her Bachelor of Science degree with a dual 
major in Mathematics and Computer Science from 
Georgia College and State University. 
 
Anne Purfield, PhD, has joined the Clinical Research 
Branch, and will divide her time between that branch 
and the Laboratory Branch. Dr. Purfield will be taking 
on a new role as the TBTC Clinical and Laboratory 
Research Coordinator. The purpose of this position is 
to bridge epidemiologic and laboratory data by 
connecting programmatic and clinical research 
outcomes with laboratory results. The goal is to 
enhance the use of laboratory data for programmatic 
and clinical purposes. Anne has a doctorate in 
Microbiology and Immunology from the University of 
North Carolina at Chapel Hill. For the past 2 years 
she has been an Officer in CDC’s Epidemic 
Intelligence Service (EIS) assigned to the Mycotic 
Diseases Branch in the Division of Foodborne, 
Waterborne, and Environmental Diseases. There she 
was engaged in investigating and responding to the 
national outbreak of fungal infections associated with 
injections of contaminated steroid from a 
compounding pharmacy. Prior to EIS, Dr. Purfield 
was a Regulatory Reviewer in the Center for Drug 
Evaluation and Research at FDA where her portfolio 
included drugs being considered for the treatment of 
TB and parasites. 
 
Anne brings to DTBE a unique combination of skills 
in the fields of epidemiology and microbiology, in 
addition to knowledge and experience regarding 
regulatory processes. This combination will be of 
great value to TBTC and the Laboratory Branch. 
While Anne is administratively housed in the Clinical 
Research Branch, she will divide her time between 
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Corporate Square (CRB) and the Roybal Campus 
(LB). She joined DTBE on July 3. 
 
Paul Regan was assigned to DTBE headquarters on 
August 11, 2014, as a program consultant with FSEB 
and will serve on the Field Operations Team-East. 
Since July 4, 2010, he had served as the TB Senior 
Public Health Advisor in Richmond, Virginia. His 
duties there included assisting with contact 
investigations, monitoring budgets, overseeing 
grants, taking a leadership role with the cooperative 
agreement and the annual progress report, and other 
duties.  
 
He was previously assigned to the Mississippi State 
Dept. of Health as Director of the Hinds County TB 
Clinic in Jackson, Mississippi. While there, he was 
selected for the International Experience and 
Technical Assistance (IETA) program, giving him the 
opportunity to travel to South Africa and provide 
technical assistance to the Global AIDS Program 
(GAP).  
 
Prior to Mississippi, Paul was assigned to the Florida 
Bureau of TB and Refugee Health in Tallahassee, 
FL. While there, he served as Area Manager of Areas 
1 and 2A, Area Coordinator for Area 5, and 
Continuity of Operations Program (COOP) 
coordinator for the Bureau, along with other duties.  
 
Paul began his CDC DTBE career in the Alabama 
Dept. of Health, providing support to local staff and 
performing disease intervention activities in an eight-
county area. Before coming to DTBE, he worked for 
the New Orleans Office of Public Health in the TB 
control program as a Disease Intervention Specialist 
II. Prior to working in public health, Paul worked for 
the Louisiana State Department of Corrections in the 
Adult Felony Probation and Parole Division as a 
Special Agent. 
 
During his years with DTBE (August 2003 to 
Present), Paul has volunteered for several temporary 
duty assignments (TDY). These have included an 
Epi-Aide in Bayou La Batre, AL, as well as TDYs in 
New Orleans, LA (post-Katrina); Fort Wayne, IN; 
Kosciusko County, IN; Providence, RI; Savannah, 
GA; and Louisville, KY.  
 
Nicole Richardson-Smith and Ann Lanner are the 
recipients of the DTBE Director’s Quarterly 
Recognition Award for the third quarter of 2014 for 
their roles in the TB Personal Stories project. 
Compelling success stories help public health 
agencies convey how health promotion programs 
work, why they are successful, and lessons learned. 
This project supports the goal of raising awareness 
about TB in the United States. Nicole and Ann 
overcame a number of challenges in getting the 
stories and videos produced and posted. Several 
stories have been used in presentations, 
publications, and social media, including Dr. 
Mermin’s 2014 Congressional briefing; the 
NCHHSTP 2013 annual report; a one pager 
“Success Story” by NCHHSTP OD; promotion on 
CDC social media; and the New York City Facebook 
promotion of their World TB Day activities. 
 
Nicole Richardson-Smith, MPH, has left CEBSB to 
join the Health Communication Team in the Division 
of Adolescent and School Health (DASH). In her new 
position, Nicole will develop a variety of 
communication products, implement and manage 
health communication projects and campaigns, and 
manage the content, organization, and design of 
DASH’s website. Nicole joined CEBSB as a Health 
Communication Specialist in March 2011. Since 
joining the Branch, Nicole has had several key 
capacities, including co-lead on the TB Personal 
Stories Project, development of the Spanish TB 
website, and development of key messages for TB 
outbreaks. Her last day in DTBE was July 10, 2014. 
 
Amy Sandul, MPH, joined the Medical Consultation 
Team in the Field Services and Evaluation Branch on 
June 30, 2014, on a 120-day detail from the 
NCHHSTP OD. She will serve as project officer for 
the 3HP surveillance activity. Amy is a health 
scientist with almost 10 years of experience in basic 
research and over 10 years of experience working in 
science policy, regulation, and administration. She 
sits on the CDC Confidentiality Review Committee 
and chairs one of the agency’s five institutional 
review boards. Ms. Sandul is a Certified IRB 
Professional and holds a Bachelor of Science degree 
in biological sciences and a Bachelor of Arts degree 
in psychology from Michigan State University. She 
also holds a Master of Public Health degree from 
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Emory University and will complete her Doctor of 
Health Sciences degree with the Arizona School of 
Health Sciences in June 2015. 
 
Colleen Scott, DrPH, MPH, has joined IRPB as one 
of DTBE’s new EIS officers. She recently completed 
her doctoral work at East Tennessee State 
University, with her dissertation evaluating the 
National Weather Service's Tsunami Ready 
Community program guidelines. Blending behavioral 
science and health education, Colleen has worked 
with CDC in Tanzania, the International Rescue 
Committee (IRC) in Kenya, and the Peace Corps in 
Zambia. She has also worked with the Refugee 
Health Branch at CDC, and the Division of the 
Civilian Volunteer Medical Reserve Corps in the 
Office of the Surgeon General. She holds an MPH 
degree from Emory University, where she worked in 
both global and behavioral public health research and 
programming. 
 
Angela Starks, PhD, MPH, was selected as the Chief 
of the Laboratory Branch (LB) in DTBE. Since 2011, 
Angela has served as the team leader for the 
Laboratory Capacity Team within LB where she 
established a cohort of laboratory consultants to 
provide oversight of the laboratory component of the 
tuberculosis cooperative agreements and provide 
education to the TB community. As team leader, 
Angela also directed operational public health 
research focused on laboratory systems. During this 
time, she has also forged significant collaborative 
relationships with partner organizations to support 
increased domestic capacity for high-quality 
laboratory diagnosis of TB. 
 
Angela came to DTBE in 2005 in what was then the 
Mycobacteriology Laboratory Branch through the 
Fellowship in Research and Science Teaching 
program at Emory University. On completion of her 
postdoctoral fellowship, she joined the laboratory as 
a Title 42 senior service fellow and conducted 
research on the molecular mechanisms of drug 
resistance for Mycobacterium tuberculosis and 
served as a co-instructor and guest lecturer at 
Spelman College. In 2008, Angela became the leader 
of the Laboratory Capacity Activity, which transitioned 
into the Laboratory Capacity Team. Angela received 
her PhD in Biomedical Sciences, with a concentration 
in Microbiology and Immunology, from the University 
of Florida and is currently pursuing an MPH in Public 
Health Administration from the University of South 
Florida, Tampa. Angela began in her new role as 
chief of the DTBE Laboratory Branch on June 15, 
2014. 
 
Brock Stewart, PhD, joined the Statistics Team of the 
Data Management and Statistics Branch on July 28, 
2014. Brock has worked in the Immunization Safety 
Office of the Division of Healthcare Quality Promotion 
since April 2010. While at the Immunization Safety 
Office, Brock contributed as lead statistician on 
numerous vaccine safety manuscripts; developed 
new methods, including in-house data mining 
capabilities; and provided consultative support to 
medical and epidemiologic staff. Brock received his 
PhD degree in Forest Biometrics and his Masters of 
Science degree in Statistics in 2007 from the 
University of Georgia. 
 
Katrina Williams joined the Data Management and 
Statistics Branch of DTBE on July 7, 2014, as a 
Systems Analyst on the TB Information Systems 
Team. Ms. Williams is a Northrop Grumman 
contractor who will be providing support to the CDC 
Information Management Services Contract. She will 
provide support to state TB program users needing 
access to DTBE’s applications. She will also work 
with public health staff to resolve data quality issues. 
Katrina has 12 years of experience working for 
Georgia’s State Tuberculosis Program, providing 
technical support to other state agencies and local 
health departments. Katrina received her Bachelor of 
Science degree in Criminal Justice at the American 
Intercontinental University and is currently working on 
her MBA at the University of Phoenix. 
 
Sherrie Wright has joined DTBE. She is a Total 
Solutions contractor who will be providing 
administrative support to DTBE. Ms. Wright has 
previously served as a Program Analyst in the Center 
for Global Health (CGH); as a Program Operations 
Assistant in the Global AIDS Program (GAP); as an 
Administrative Assistant in the OID/NCHHSTP; and 
as an Administrative Assistant IV in the Procurement 
and Grants Office (PGO). 
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Courtney Yuen, PhD, left DTBE in June 2014, after 2 
years as an Epidemic Intelligence Service (EIS) 
officer in SEOIB. During her time with DTBE, she 
investigated outbreaks and worked toward the 
establishment of surveillance definitions for U.S.-
Mexico binational TB cases. In addition, she 
conducted analyses on a variety of topics including 
the association between mycobacterial lineage and 
acquired drug resistance, a comparison of TB 
incidence trends among HIV-positive and HIV-
negative persons in Kenya, and the epidemiology of 
recent TB transmission in the United States. 
Courtney is currently continuing research in TB 
epidemiology as an Instructor in the Division of 
Global Health Equity at Brigham and Women’s 
Hospital/Harvard Medical School. 
 
CALENDAR OF EVENTS 
 
September 9–11, 2014 
ASTHO Annual Meeting and Policy Summit 
Albuquerque, New Mexico 
 Learn More » 
Association of State and Territorial Health Officers 
(ASTHO) 
 
Sept. 16–18, 2014 
TB Education and Training Network (TB ETN) and 
TB Program Evaluation Network (TB PEN) Joint 
Conference 
Atlanta, GA 
Peri Hopkins/Awal Khan 
 
Oct. 15–18, 2014 
The 51st Annual Denver TB Course 
Denver, Colorado 
The 51st Semi-Annual Denver TB Course — National 
Jewish Health 
 
Oct. 28–Nov. 1, 2014 
45th Union World Conference on Lung Health 
Barcelona, Spain 
International Union Against Tuberculosis and Lung 
Disease 
Click here to download the Barcelona 2014 Brochure  
http://barcelona.worldlunghealth.org 
  
November 4–5, 2014 
20th Annual Four Corners TB & HIV Conference 




Nov. 15–19, 2014 
142nd APHA Annual Meeting 
New Orleans, LA 
American Public Health Association (APHA) 
 
January 22–27, 2015 
Host Response in TB (J3)  





February 23–26, 2015 
Conference on Retroviruses and Opportunistic 
Infections (CROI) 
Seattle, WA 
Contact: CROI www.croi2014.org/  
 
February 26–28, 2015 






March 8–11, 2015 
International Conference on Emerging Infectious 
Diseases (ICEID) Conference 
Atlanta, GA 
Lori Armstrong lra0@cdc.gov 
 
May 15–20, 2015 





May 18–21, 2015 
APHL Annual Meeting and 9th Government 
Environmental Laboratory Conference 
Indianapolis, IN 
http://www.aphl.org/conferences/Pages/default.aspx  
